Immediate Rectal Suction Biopsy Required
This 5-year-old with absent RAIR on manometry and lifelong failure to pass stool requires immediate rectal suction biopsy (RSB) to confirm or exclude Hirschsprung disease (HD), as absent RAIR has 100% sensitivity but only 55-74% specificity for HD 1, 2.
Diagnostic Algorithm
Step 1: Confirm Manometry Findings
- Absent RAIR is the critical finding that mandates further workup
- While ARM has excellent negative predictive value (99-100%), its positive predictive value is only 55-56% 1, 2
- This means absent RAIR could represent either HD or internal anal sphincter achalasia (IASA)
Step 2: Distinguish HD from IASA
Key clinical differentiators:
Hirschsprung Disease typically presents with:
- Delayed meconium passage (>48 hours after birth)
- Earlier symptom onset (often neonatal period)
- Younger age at diagnosis
- More severe, unremitting symptoms 3
Internal Anal Sphincter Achalasia typically presents with:
- Normal timing of meconium passage
- Later onset of symptoms
- Older age at diagnosis
- May have abnormal contrast enema but less severe than HD 3
In this case: A 5-year-old with symptoms "since birth" strongly suggests HD over IASA, but biopsy confirmation is mandatory.
Step 3: Obtain Rectal Suction Biopsy
RSB remains the gold standard with 97% sensitivity and 97% specificity 2. The biopsy should include:
- Histology for ganglion cells
- Acetylcholinesterase histochemistry
- Sample taken at least 2-3 cm above the dentate line
Critical pitfall: Never rely on ARM alone when RAIR is absent. Among children with absent RAIR, only approximately 70-80% actually have HD 3. The remaining 20-30% have IASA or other conditions that would be inappropriately treated with pull-through surgery.
Treatment Planning
If HD Confirmed:
Definitive surgical management with laparoscopic-assisted endorectal pull-through (ERPT) is indicated 4. This is the standard of care for HD and addresses the underlying aganglionic segment.
If IASA Confirmed (HD excluded):
Treatment options include:
- Aggressive medical management with oral laxatives (54% managed with laxatives alone) 3
- Botulinum toxin injection to internal anal sphincter (55% positive response rate) 3
- Biofeedback therapy in age-appropriate patients 5
Additional Diagnostic Considerations
Contrast enema may provide supportive evidence:
- Transition zone suggests HD
- Abnormal findings more common in both HD and IASA compared to functional constipation 3
- However, this is adjunctive only—biopsy remains definitive
Do not delay biopsy for additional imaging studies in this clinical scenario. The combination of lifelong symptoms and absent RAIR demands tissue diagnosis.
Quality of Life and Morbidity Considerations
Untreated HD carries significant morbidity:
- Risk of enterocolitis (potentially life-threatening)
- Chronic megacolon
- Failure to thrive
- Severe quality of life impairment
Misdiagnosis also carries morbidity:
- Unnecessary surgery if IASA is mistaken for HD
- Inadequate treatment if HD is missed
The 5-year delay in diagnosis is already concerning and emphasizes the urgency of definitive diagnosis. ARM's 100% negative predictive value means HD can be confidently excluded when RAIR is present 2, but the converse (absent RAIR = HD) requires histologic confirmation given the 20-30% false positive rate 3.